特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のレムデシビル市場:COVID 19パンデミック下での成長と変化

Remdesivir Global Market Report 2020-30: COVID 19 Growth and Change

発行 The Business Research Company 商品コード 950451
出版日 ページ情報 英文 200 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。
世界のレムデシビル市場:COVID 19パンデミック下での成長と変化 Remdesivir Global Market Report 2020-30: COVID 19 Growth and Change
出版日: 2020年07月17日 ページ情報: 英文 200 Pages
概要

当レポートは、世界のレムデシビル市場を調査したもので、国別、地域別の分析、競合情勢、合併と買収の動き、市場のトレンドや戦略、今後の展望や成長性の分析などを通じ、最大の市場と急成長している市場、全般的な景気動向や人口動態、他の隣接市場との関連、今後市場の方向性を決定づける要因を明らかにしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特性

第3章 市場規模と成長性

  • 世界市場の実績:2015年~2019年
    • 市場の成長促進要因
    • 市場の成長阻害要因
  • 世界市場の予測:2019年~2023年、2025年、2030年
    • 市場の成長促進要因
    • 市場の成長阻害要因

第4章 市場区分

  • 投与経路別市場の実績と予測
    • 経口投与
    • 静脈注射
  • 剤形別市場の実績と予測
    • 錠剤
    • 凍結製剤
    • 凍結乾燥製剤
  • 流通チャネル別市場の実績と予測
    • 病院
    • クリニック
    • ドラッグストア/薬局
    • オンライン
    • その他

第5章 地域別、国別の分析

  • 地域別、国別の実績と予測

第6章 アジア太平洋

  • 市場の概要
  • 実績と予測

第7章 中国

  • 市場の概要
  • 実績と予測

第8章 インド

  • 市場の概要
  • 実績と予測

第9章 日本

  • 市場の概要
  • 実績と予測

第10章 オーストラリア

  • 実績と予測

第11章 インドネシア

  • 実績と予測

第12章 韓国

  • 実績と予測

第13章 西欧

  • 市場の概要
  • 実績と予測

第14章 英国

  • 市場の概要
  • 実績と予測

第15章 ドイツ

  • 実績と予測

第16章 フランス

  • 実績と予測

第17章 東欧

  • 市場の概要
  • 実績と予測

第18章 ロシア

  • 実績と予測

第19章 北米

  • 市場の概要
  • 実績と予測

第20章 米国

  • 市場の概要
  • 実績と予測

第21章 南米

  • 市場の概要
  • 実績と予測

第22章 ブラジル

  • 実績と予測

第23章 中東

  • 市場の概要
  • 実績と予測

第24章 アフリカ

  • 市場の概要
  • 実績と予測

第25章 競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Gilead Sciences, Inc.
    • Bright Gene
    • Hainan Haiyao
    • Kelun Pharma
    • Hunan Warrant Pharmaceutical

第26章 主な合併と買収

第27章 市場の動向と戦略

第28章 今後の展望と将来性の分析

第29章 付録

目次

Remdesivir Global Market Report 2020-30: COVID 19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global remdesivir market.

This report focuses on remdesivir market which is experiencing strong growth. The report gives a guide to the remdesivir market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the remdesivir? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Remdesivir market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider remdesivir market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The remdesivir market section of the report gives context. It compares the remdesivir market with other segments of the remdesivir market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, remdesivir indicators comparison.

Scope

Markets Covered: 1) By Route of Administration: Oral; Intravenous

2) By Dosage Form: Tablets; Frozen Solution; Lypholized Solution

3) By Distribution Channel: Hospitals; Clinics; Drug Stores/Pharmacies; Online; Others

Companies Mentioned: Gilead Sciences, Inc.; Bright Gene; Hainan Haiyao; Kelun Pharma; Hunan Warrant Pharmaceutical

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Remdesivir Market Characteristics

3. Remdesivir Market Size And Growth

  • 3.1. Global Remdesivir Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Remdesivir Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Remdesivir Market Segmentation

  • 4.1. Global Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Oral
    • Intravenous
  • 4.2. Global Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Tablets
    • Frozen Solution
    • Lypholized Solution
  • 4.3. Global Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospitals
    • Clinics
    • Drug Stores/Pharmacies
    • Online
    • Others

5. Remdesivir Market Regional And Country Analysis

  • 5.1. Global Remdesivir Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Remdesivir Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Remdesivir Market

  • 6.1. Asia-Pacific Remdesivir Market Overview
  • 6.2. Asia-Pacific Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Remdesivir Market

  • 7.1. China Remdesivir Market Overview
  • 7.2. China Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Remdesivir Market

  • 8.1. India Remdesivir Market Overview
  • 8.2. India Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Remdesivir Market

  • 9.1. Japan Remdesivir Market Overview
  • 9.2. Japan Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Remdesivir Market

  • 10.1. Australia Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Remdesivir Market

  • 11.1. Indonesia Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Remdesivir Market

  • 12.1. South Korea Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Remdesivir Market

  • 13.1. Western Europe Remdesivir Market Overview
  • 13.2. Western Europe Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Remdesivir Market

  • 14.1. UK Remdesivir Market Overview
  • 14.2. UK Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Remdesivir Market

  • 15.1. Germany Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Remdesivir Market

  • 16.4. France Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Remdesivir Market

  • 17.1. Eastern Europe Remdesivir Market Overview
  • 17.2. Eastern Europe Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Remdesivir Market

  • 18.1. Russia Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Remdesivir Market

  • 19.1. North America Remdesivir Market Overview
  • 19.2. North America Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Remdesivir Market

  • 20.1. USA Remdesivir Market Overview
  • 20.2. USA Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Remdesivir Market

  • 21.1. South America Remdesivir Market Overview
  • 21.2. South America Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Remdesivir Market

  • 22.1. Brazil Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Remdesivir Market

  • 23.1. Middle East Remdesivir Market Overview
  • 23.2. Middle East Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Remdesivir Market

  • 24.1. Africa Remdesivir Market Overview
  • 24.2. Africa Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Remdesivir Market Competitive Landscape And Company Profiles

  • 25.1. Remdesivir Market Competitive Landscape
  • 25.2. Remdesivir Market Company Profiles
    • 25.2.1. Gilead Sciences, Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Bright Gene
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Hainan Haiyao
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Kelun Pharma
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Hunan Warrant Pharmaceutical
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Remdesivir Market

27. Remdesivir Market Trends And Strategies

28. Remdesivir Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer